Evidence map›Paper›PMID 31601031›Full record

ReviewInternational journal of molecular sciences2019

Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications.

Daniel Fernández-Villa, Maria Rosa Aguilar, Luis Rojo

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Disclosing New Insights on Pyrazolo[3,4-Journal of microbiology and biotechnology · 2025
    Article
  8. Article
  9. MTHFD2: A Retrospective and a Glance into the Future.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daniel Fernández-VillaInstituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain. dafer-vi@hotmail.com.
Maria Rosa AguilarInstituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain. mraguilar@ictp.csic.es.
Luis RojoInstituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain. rojodelolmo@ictp.csic.es.

Funding

PROOPIOMELANOCORTIN GENE REGULATIONR03TW000511 · FIC · OREGON HEALTH AND SCIENCE UNIVERSITY · PI LOW, MALCOLM JAMES · 1995 to 1997
–
Consejo Superior de Investigaciones Científicas JAEINT18-EX0511Ministerio de Ciencia e Innovación MAT201573656-JIN)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Infective AgentsDrug ResistanceFolic Acid AntagonistsHumansImmunologic FactorsImmunomodulationMicrobial Sensitivity TestsStructure-Activity RelationshipAnti-Infective AgentsFolic Acid AntagonistsImmunologic FactorsantibacterialsantibioticsantifolatesantimalarialFolic acid antagonistsimmunomodulationsulfonamides

Identifiers

PMID31601031
PMCPMC6829374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.